# Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

> **NCT00832182** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 75 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin aspart
- **DRUG:** insulin NPH

## Key facts

- **NCT ID:** NCT00832182
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12-22
- **Primary completion:** 2002-11-25
- **Final completion:** 2002-11-25
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832182, "Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00832182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*